News
The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).
Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the prevention of mpox, currently deemed a public health emergency by the WHO.
The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...
Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or elevated risk of chikungunya. COPENHAGEN, Denmark, ...
Mpox and Smallpox Threats: Vaccine Development and Biosecurity Policy ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...
The following is the full transcript of an interview with Dr. Peter Marks, former head of FDA's Center for Biologics ...
People continue to cite religion as a means not to get vaccines despite their safety and effectiveness in disease prevention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results